DNA ID: Take ownership of your DNA, help cure genetic diseases

by Craig Calderone

DNA ID is a company designed for you, as a human being to take control of your most identifying trait, your DNA, while helping medical research increase velocity to clinical trials.
New york, United States Genetic Disorders Blockchain PharmaTech

All Team Company Innovation Details Supporters Comments Updates

About our project

The problem we solve: - Time - Industry research time to create new drugs takes too long (12 years) - Cost - It takes, on average, over $350M to get 1 new drug from the laboratory onto the pharmacy shelf - No easy way to access research participants - currently a bespoke effort

About our solution: A mobile application where contributors can rent out their DNA to medical researchers, make money in the process and help cure disease

Progress to date:

Currently we are developing the prototype of DNA ID. We've developed an easy workflow for contributors to order a saliva kit to have their DNA sequenced, and a conducive way for them to share that information with the Medical research community. 

About Our Team

Creator: Craig Calderone

Location: New York

Bio: Craig is a co-founder that comes from a background in big data. Having worked at NASDAQ, Techstars, Chartbeat and Leanplum, he is driving product vision. He holds a degree in Economics from Villanova University.

Title: Co-Founder

About Team Members

Paul Smith
Co-Founder, BA in Human Ecology
Biography: PJ is a co-founder that comes from a background in genetics and biomedical science. Having worked at Yale University and The Jackson Laboratory and holds a patent for a small molecule treatment for cystic fibrosis that's currently in FDA stage 1 clinical trials.
Title: Co-Founder
Advanced Degree(s): BA in Human Ecology
LinkedIn: https://www.linkedin.com/in/paultsmithjr/

Mike Mcdevitt
Co-founder, Bachelors civil engineering
Biography: Michael is a co-founder that comes from a background in Civil Engineering and is a self-taught developer. He will be leading the technical development of our platform.
Title: Co-founder
Advanced Degree(s): Bachelors civil engineering

About Our Company

DNA ID

Location: 539 Atlantic Ave
New York 11217

Founded: 2017

Website: https://www.dnaid.co/

Twitter: @DNABlockchain

Product Stage: Prototype/MVP

YTD Sales: Working on it

Employees: 1-2

Innovation Details

Intellectual Property Summary

We are covering all Intellectual Property under the Apache License https://www.apache.org/licenses/LICENSE-2.0

Clinical Information

https://useast.ensembl.org/index.html
https://www.ncbi.nlm.nih.gov/genome/guide/human/
http://www.modernhealthcare.com/article/20180129/NEWS/180129893
https://en.wikipedia.org/wiki/Genome-wide_association_study
https://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/
https://www.illumina.com/documents/products/techspotlights/techspotlight_sequencing.pdf
https://clinicaltrials.gov/ct2/show/NCT03173573?term=FDL&rank=4
https://www.genome.gov/27530645/faq-about-pharmacogenomics/
https://www.genome.gov/images/content/genetic_testing.jpg
https://gizmodo.com/the-consumer-dna-testing-market-is-already-booming-but-1822237918
http://www.strategyr.com/MarketResearch/Genetic_Testing_Market_Trends.asp
http://blog.dnagenotek.com/microbiome/harvard-t.h.-chan-school-of-public-health-selects-dna-genoteks-omnigene-devices-for-microbiome-biobank?utm_campaign=Microbiome&utm_source=hs_email&utm_medium=email&utm_content=61520335&_hsenc=p2ANqtz-_0EbXsz9irhCuUnt9krO_df-SPLm9A-PhF6P1Q46HtidGQs-IL5oS5EthgYZtCze5jo4OBQZ80ZxKLr6gAv11wvcmG7w&_hsmi=61520335
https://www.prnewswire.com/news-releases/global-1193-billion-pharmacogenomics-market-2014-2017--2024---research-and-markets-300442497.html

Regulatory Status

We will be using all FDA approved materials. 

How we will use the funds raised

The funds generated here will be used to start and pay for the sequencing of the saliva samples that we collect. It's expensive to sequence the entire genome, but it's getting cheaper by the day. The funds raised here will be a small piece in the overall funding plan but will be a great start!!

Thank You

DNA sequencing is becoming more and more prevelant and publicly available through commercial companies. We are a company that is going to do it right. We don't want to sell your data, in fact we won't even have access to it. We are asking for your help to put the ownership of your DNA back in your hands!

Supporters

Comments

Login to post your comment!
Click here to Login

Updates

    No updates found .

$ 20,000

pledged of $ 100,000 goal

$ 20,000

Investor interest to date.

  • This campaign has ended but you can still get involved.
    See options below.

2

Interest
Score

0

Adoption
Score


Rewards All contributions are tax-deductible.